Related Experiment Videos
ASO Author Reflections: Adjuvant Therapy for Stage III Melanoma With or Without Completion Lymph Node Dissection
Robert J Torphy1, Martin D McCarter2, Ana L Gleisner2
1Department of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. robert.torphy@cuanschutz.edu.
Annals of Surgical Oncology
|September 25, 2021
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Decitabine reverses innate immune gene suppression in rare melanomas.
Molecular cancer therapeutics·2026
mRNA Vaccines for Cancer Treatment.
Surgical oncology clinics of North America·2026
GPR182 is a lipoprotein receptor for dietary fat absorption.
The Journal of clinical investigation·2026
Trends and Outcomes of Surgical Reconstruction of the IVC after Oncologic Resection.
Journal of the American College of Surgeons·2026
ASO Editorial: Lymph Node Dissection in the Immunotherapy Era: Friend or Foe?
Annals of surgical oncology·2026
Determinants of Non-Receipt of Guideline-Concordant Treatment in Pancreatic Cancer: A Classification Tree Analysis.
Annals of surgical oncology·2026
A Phase II Trial of Pembrolizumab plus Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Biliary Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
The hormetic landscape: from evolutionary origination to mechanistic pathways in therapeutics.
Cell cycle (Georgetown, Tex.)·2026
Clinical Outcomes of Gradual Corticosteroid Tapering for Immune Checkpoint Inhibitor-Induced Liver Injury.
Hepatology research : the official journal of the Japan Society of Hepatology·2026